Dec 07, 2020 / 09:00PM GMT
Operator
Greetings, and welcome to the CryoLife PROACT Xa Clinical Trial Conference Call. (Operator Instructions) Please note that this conference is being recorded.
I will now turn the conference over to our host, Pat Mackin, President and Chief Executive Officer. Thank you. You may begin.
James Patrick Mackin - CryoLife, Inc. - Chairman, President & CEO
Thank you, and good afternoon, everyone. Welcome to the CryoLife investor call to discuss our PROACT Xa clinical trial.
I'm just going to throw up our forward-looking statement briefly so you can look at that.
So during this 1-hour call, I'm going to kick it off with a few opening slides to put the trial into context for our overall business. Then I'm going to turn the call -- the majority of this call is going to be Dr. John Alexander presenting, and then we'll have time at the end for Q&A.
So just a few slides on CryoLife. So when I joined about 6 years ago, we had a couple main product lines, BioGlue and our homograft tissue valves and vascular tissue. These products
CryoLife Inc - Discussing PROACT Xa Clinical Trial Transcript
Dec 08, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers